You are here

A Japanese phase I/II study of NS-065/NCNP-01, exon 53 skipping drug, in patients with Duchenne muscular dystrophy - a dose-finding study

Authors: 
Komaki H, Takeshima Y, Matsumura T, Ozasa S, Funato M, Egawa Y, Takeda S
Citation: 
Neuromusc Disord. 2018;28:P129. doi:10.1016/j.nmd.2018.06.157
Abstract: 
no abstract available
Epub: 
Not Epub
Link to Publication: 
https://www.nmd-journal.com/article/S0960-8966(18)30720-X/fulltext
Organism or Cell Type: 
human
Delivery Method: 
i.v. infusion